A Healthy Dose 2017 JP Morgan Healthcare Conference Recap
Jan 18, 2017
Sean Duffy, CEO of Omada Health, talks product development and reimbursement from an operator's view. Chrissy Farr, healthcare tech journalist, covers media, policy, and public perception. Ambar Bhattacharyya, healthcare investor, offers perspective on deals and market trends. They recap JPMorgan themes: political impact on deals, big tech and retail in care, diagnostics buzz, valuation caution, and the push for care at home.
AI Snips
Chapters
Transcript
Episode notes
Grail Dominated Conversations At JPM
- Grail dominated conversations at JPM with its planned $1.3B raise and early-detection mission.
- Chrissy noted even biotech peers corrected her earlier reporting, showing how much attention the round attracted.
Grail Raises Big Bets On Early Cancer Screening
- Grail's huge Series B highlights big bets on early cancer detection despite heavy scientific and clinical trial challenges.
- Panel noted the likely need for hundreds of thousands of patients and much of the $1.3B will fund trials and validation.
Voice Assistants Offer Low Hanging Healthcare Use Cases
- Voice assistants and home speech recognition are a near-term platform for incremental healthcare use cases.
- Sean Duffy pointed to simple applications like voice-triggered nurse calls and in-room commands as early wins.